Literature DB >> 33300192

Pediatric fibromyxoid soft tissue tumor with PLAG1 fusion: A novel entity?

Catherine T Chung1,2, Cristina R Antonescu3, Brendan C Dickson2,4, Rose Chami1,2, Paula Marrano1, Rong Fan5, Mary Shago2,6, Meera Hameed3, Paul S Thorner2.   

Abstract

The classification of undifferentiated soft tissue tumors continues to evolve with the expanded application of molecular analysis in clinical practice. We report three cases of a unique soft tissue tumor in young children (5 months to 2 years old) displaying a purely fibromyxoid histology, with positive staining for desmin and CD34. In two cases, RNA sequencing detected a YWHAZ-PLAG1 gene fusion, while in the third case, a previously unreported EEF1A1-PLAG1 fusion was identified. PLAG1 fusions have been reported in several pathologic entities including pleomorphic adenoma, myoepithelial tumors of skin and soft tissue, and lipoblastoma, the latter occurring preferentially in young children. In these tumors, expression of a full length PLAG1 protein comes under the control of the constitutively active promoter of the partner gene in the fusion, and the current cases conform to that model. Overexpression of PLAG1 was confirmed by diffusely positive immunostaining for PLAG1 in all three cases. Our findings raise the possibility of a novel fibromyxoid neoplasm in childhood associated with these rare PLAG1 fusion variants. The only other report of a PLAG1-YWHAZ fusion occurred in a pediatric tumor diagnosed as a "fibroblastic lipoblastoma." This finding raises the possibility of a relationship with our three cases, even though our cases lacked any fat component. Further studies with regard to a shared pathogenesis are required.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  EEF1A1; PLAG1; YWHAZ; lipoblastoma; soft tissue; translocation; tumor

Mesh:

Substances:

Year:  2020        PMID: 33300192      PMCID: PMC8358975          DOI: 10.1002/gcc.22926

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  51 in total

1.  The 5' terminal oligopyrimidine tract of human elongation factor 1A-1 gene functions as a transcriptional initiator and produces a variable number of Us at the transcriptional level.

Authors:  Akiko Shibui-Nihei; Yoshihiro Ohmori; Kenichi Yoshida; Jun-ichi Imai; Ikurou Oosuga; Makoto Iidaka; Yutaka Suzuki; Junko Mizushima-Sugano; Kiyomi Yoshitomo-Nakagawa; Sumio Sugano
Journal:  Gene       Date:  2003-06-05       Impact factor: 3.688

2.  Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.

Authors:  Nora Katabi; Ronald Ghossein; Alan Ho; Snjezana Dogan; Lei Zhang; Yun-Shao Sung; Cristina R Antonescu
Journal:  Hum Pathol       Date:  2014-09-07       Impact factor: 3.466

3.  PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland.

Authors:  Atsuji Matsuyama; Masanori Hisaoka; Hiroshi Hashimoto
Journal:  Pathol Int       Date:  2011-11-03       Impact factor: 2.534

4.  NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.

Authors:  Brendan C Dickson; Yun-Shao Sung; Marc K Rosenblum; Victor E Reuter; Mohammed Harb; Jay S Wunder; David Swanson; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-05       Impact factor: 6.394

5.  Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.

Authors:  A K Aström; M L Voz; K Kas; E Röijer; B Wedell; N Mandahl; W Van de Ven; J Mark; G Stenman
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

6.  Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners.

Authors:  Karen Fritchie; Lu Wang; Zhaohong Yin; Joy Nakitandwe; Dale Hedges; Andrew Horvai; Jorge Torres Mora; Andrew L Folpe; Armita Bahrami
Journal:  Mod Pathol       Date:  2020-10-23       Impact factor: 7.842

7.  Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation.

Authors:  Cristina R Antonescu; Lei Zhang; Sung Yun Shao; Juan-Miguel Mosquera; Ilan Weinreb; Nora Katabi; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2013-04-30       Impact factor: 5.006

8.  Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.

Authors:  Andrea Zatkova; Jean-Marie Rouillard; Wolfgang Hartmann; Barbara J Lamb; Rork Kuick; Markus Eckart; Dietrich von Schweinitz; Arend Koch; Christa Fonatsch; Torsten Pietsch; Sam M Hanash; Katharina Wimmer
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

Review 9.  New advances in the molecular classification of pediatric mesenchymal tumors.

Authors:  Albert J H Suurmeijer; Yu-Chien Kao; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2018-10-11       Impact factor: 5.006

10.  Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity.

Authors:  Alvaro Blanch; Fiona Robinson; Ian R Watson; Lynn S Cheng; Meredith S Irwin
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

View more
  3 in total

1.  Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.

Authors:  Wanming Hu; Li Yuan; Xinke Zhang; Yang Ni; Dongchun Hong; Zhicai Wang; Xiaomin Li; Yuan Ling; Chao Zhang; Wanglong Deng; Minqi Tian; Ran Ding; Chao Song; Jianmin Li; Xing Zhang
Journal:  Cancer Sci       Date:  2022-03-10       Impact factor: 6.518

2.  Pleomorphic adenoma gene 1 (PLAG1) promotes proliferation and inhibits apoptosis of bovine primary myoblasts through the PI3K-Akt signaling pathway.

Authors:  Jian Wang; Yongzhen Huang; Jiawei Xu; Binglin Yue; Yifan Wen; Xiao Wang; Chuzhao Lei; Hong Chen
Journal:  J Anim Sci       Date:  2022-04-01       Impact factor: 3.338

3.  A unique epithelioid vascular neoplasm of bone characterized by EWSR1/FUS-NFATC1/2 fusions.

Authors:  Nooshin K Dashti; Brendan C Dickson; Lei Zhang; Ziyu Xie; Gunnlaugur Pétur Nielsen; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2021-08-06       Impact factor: 5.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.